First-Line Surgery for CD and Possibility of Precision Medicine for UC

Miguel Regueiro, MD

Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland

By Miguel Regueiro, MD, with Marcus A. Banks

This month in The Regueiro Report, I examine whether surgery should be the first-line treatment for some people with Crohn’s disease (CD) and discuss the possibility of using precision medicine to target treatment of ulcerative colitis (UC).

Gastroenterologists typically manage moderate to severe CD with a biologic